Far Infrared Radiation Treatment for Bipolar Condition

Bipolar Disorder Clinical Trial

Official title:

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00573196
• Other study ID #: GAAD-BPC-CTP1
• Status: Active, not recruiting
• Phase: Phase 1
• First received: December 12, 2007
• Last updated: August 14, 2009
• Start date: September 2006
• Est. completion date: June 2008

Study information

• Verified date: August 2009
• Source: GAAD Medical Research Institute Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

Description:

A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant & entrepreneur Ted Turner, excelled in life due to the additional brain power!

The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3
• Est. completion date: June 2008
• Est. primary completion date: February 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia

Exclusion Criteria:

• Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Bipolar Disorder

Intervention

Radiation:
• Far infrared
Far infrared radiation (5µm to 15µm wavelength)

Locations

Country	Name	City	State
Canada	The Centre for Incurable Diseases	Mississauga	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
GAAD Medical Research Institute Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.		2 years	No
Secondary	The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.		2 years	No